http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111658641-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_850a17186ff51f03c607cf42a534a635 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate | 2015-02-25^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77148558bf149ec42ee74828196e0604 |
| publicationDate | 2020-09-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111658641-A |
| titleOfInvention | Development-inhibiting or improving agent for chronic kidney disease |
| abstract | An object of the present invention is to provide an agent for inhibiting or ameliorating the progression of chronic kidney disease by administration to patients with chronic kidney disease whose renal function deteriorates rapidly. The present invention relates to an agent for suppressing or improving the progression of chronic kidney disease containing 5-hydroxy-1-methylhydantoin as an active ingredient. This agent has a remarkable effect on chronic kidney disease patients whose renal function deteriorates rapidly. The present agent is very useful as a highly safe agent capable of suppressing or improving the progression of deterioration of renal function in patients with chronic kidney disease who are rapidly progressing and for which there is currently no effective therapeutic drug that can be easily taken. |
| priorityDate | 2014-02-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 38 of 38.